Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
The New England Journal of Medicine|August 9, 1990
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitusA S Kennington, C R Hill, J Craig, et al.The Journal of Laboratory and Clinical Medicine|November 24, 1999
Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruliK Sade, D Schwartz, Y Wolman, et al.International Journal of Clinical Practice|September 29, 2009
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statementA G Unnikrishnan, J Tibaldi, M Hadley-Brown, et al.Diabetologia|July 6, 2004
Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetesY Anis, O Leshem, H Reuveni, et al.International Journal of Dermatology|September 16, 1999
Maggot therapy for the treatment of intractable woundsK Y Mumcuoglu, A Ingber, L Gilead, et al.Human Mutation|February 19, 2000
Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiencyW Lissens, L De Meirleir, S Seneca, et al.The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.The American Journal of Physiology|November 1, 1990
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQF Zurlo, S Lillioja, A Esposito-Del Puente, et al.Clinical Pharmacology and Therapeutics|September 27, 2013
The importance of short-term off-target effects in estimating the long-term renal and cardiovascular protection of angiotensin receptor blockersP A Smink, Y Miao, M J C Eijkemans, et al.Diabetes, Obesity & Metabolism|October 8, 2015
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trialL A Leiter, H Teoh, O Mosenzon, et al.Pageof 14